Triple

T15983031
Position Surface form Disambiguated ID Type / Status
Subject Juno Therapeutics E387620 entity
Predicate foundedBy P104 FINISHED
Object Phil Greenberg NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Phil Greenberg | Statement: [Juno Therapeutics, foundedBy, Phil Greenberg]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Phil Greenberg
Context triple: [Juno Therapeutics, foundedBy, Phil Greenberg]
  • A. Michael Greenberg
    Michael Greenberg is a prominent American neuroscientist renowned for his pioneering work on activity-dependent gene expression in the brain.
  • B. Michael Greenberg
    Michael Greenberg is an American businessman best known as the co-founder and longtime executive leader of the global footwear company Skechers.
  • C. Mike Greenberg
    Mike Greenberg is an American television and radio sportscaster best known as a longtime ESPN personality and co-host of popular sports talk shows.
  • D. Dan Greenburg
    Dan Greenburg is an American author and humorist best known for his satirical books and children's series such as "The Zack Files."
  • E. Martin Greenberg
    Martin Greenberg was an American publisher and editor best known for co-founding Gnome Press, which helped popularize early science fiction literature.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Phil Greenberg
Target entity description: Phil Greenberg is an immunologist and biotech entrepreneur known for pioneering work in cancer immunotherapy and co-founding Juno Therapeutics.
  • A. Michael Greenberg
    Michael Greenberg is a prominent American neuroscientist renowned for his pioneering work on activity-dependent gene expression in the brain.
  • B. Michael Greenberg
    Michael Greenberg is an American businessman best known as the co-founder and longtime executive leader of the global footwear company Skechers.
  • C. Mike Greenberg
    Mike Greenberg is an American television and radio sportscaster best known as a longtime ESPN personality and co-host of popular sports talk shows.
  • D. Dan Greenburg
    Dan Greenburg is an American author and humorist best known for his satirical books and children's series such as "The Zack Files."
  • E. Martin Greenberg
    Martin Greenberg was an American publisher and editor best known for co-founding Gnome Press, which helped popularize early science fiction literature.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da94ccc819083d187f5dc6a123e completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e15756d6488190ac35da00e96ce21d completed April 16, 2026, 9:40 p.m.
Created at: April 10, 2026, 4:54 a.m.